Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for iBio (IBIO) over the last 14 years, with Q4 2025 value amounting to $141000.0.

  • iBio's Depreciation and Depletion rose 1557.38% to $141000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $506000.0, marking a year-over-year decrease of 816.7%. This contributed to the annual value of $484000.0 for FY2025, which is 2413.79% down from last year.
  • According to the latest figures from Q4 2025, iBio's Depreciation and Depletion is $141000.0, which was up 1557.38% from $123000.0 recorded in Q3 2025.
  • iBio's Depreciation and Depletion's 5-year high stood at $743000.0 during Q2 2022, with a 5-year trough of $117000.0 in Q4 2022.
  • Moreover, its 5-year median value for Depreciation and Depletion was $144000.0 (2021), whereas its average is $229800.0.
  • In the last 5 years, iBio's Depreciation and Depletion surged by 49579.83% in 2022 and then crashed by 8307.48% in 2023.
  • iBio's Depreciation and Depletion (Quarter) stood at $517000.0 in 2021, then plummeted by 77.37% to $117000.0 in 2022, then skyrocketed by 40.17% to $164000.0 in 2023, then decreased by 25.61% to $122000.0 in 2024, then rose by 15.57% to $141000.0 in 2025.
  • Its Depreciation and Depletion was $141000.0 in Q4 2025, compared to $123000.0 in Q3 2025 and $121000.0 in Q2 2025.